Posts

Showing posts from July, 2019

“Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection - MD Linx” plus 1 more

Image
“Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection - MD Linx” plus 1 more Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection - MD Linx Posted: 31 Jul 2019 04:15 AM PDT [unable to retrieve full-text content] Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection    MD Linx In this retrospective analysis, researchers ascertained if nasal thallium-201 uptake of the olfactory cleft and olfactory bulb (OB) varies between patients with ... Asthma in the Elderly: Important Considerations for Diagnosis and Treatment - Pulmonology Advisor Posted: 31 Jul 2019 08:30 AM PDT Asthma affects between 4% and 13% of adults in the United States aged 65 years and older. 1 People in this older population are >5 times more likely to die from as

Health and education beyond borders - The Express Tribune

Image
Health and education beyond borders - The Express Tribune Health and education beyond borders - The Express Tribune Posted: 22 Jul 2019 10:23 PM PDT China has fast change­d its course of econom­ic develo­pment at the turn of the centur­y The writer is Foreign Research Associate, Centre of Excellence CPEC, Islamabad The New Silk Road aims to connect China's grand route with Africa, Asia, and Europe through cyberspace and physical space, promising prosperity and innovation. One Belt, One Road (OBOR), or Belt and Road Initiative (BRI), promises the construction of a massive $1 trillion infrastructure including highways, dry and seaports, power plants, and state of the art telecommunication network. One Belt, One Road has been highly criticised for the wide flow of benefits mostly to China. Will the unprecedented influx of development financing improve the Human Development Index of people living along the belt? China has fast chan

Alexion Receives Positive CHMP Opinion for SOLIRIS® (eculizumab) for the Treatment of NMOSD - BioSpace

Image
Alexion Receives Positive CHMP Opinion for SOLIRIS® (eculizumab) for the Treatment of NMOSD - BioSpace Alexion Receives Positive CHMP Opinion for SOLIRIS® (eculizumab) for the Treatment of NMOSD - BioSpace Posted: 26 Jul 2019 08:30 AM PDT NMOSD is a rare, devastating, complement-mediated disorder of the central nervous system characterized by relapses, also referred to as attacks. Each attack results in stepwise accumulation of disability, including blindness and paralysis and sometimes premature death. NMOSD disproportionately strikes young women in the prime of their lives, with the average age of first onset at just 39 years. Previously known as Devic's Disease, NMOSD is often confused with other neurological illnesses such as multiple sclerosis (MS), which can lead to delays in diagnosis and treatment with medicines that can worsen disease progression. "Each and every NMOSD attack has the potential to result in serious, irrevers

Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment: Clinical Trials Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 Strategic Analysis and Future Growth 2019-2025 - The Market Plan

Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment: Clinical Trials Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 Strategic Analysis and Future Growth 2019-2025 - The Market Plan Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment: Clinical Trials Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 Strategic Analysis and Future Growth 2019-2025 - The Market Plan Posted: 31 Jul 2019 07:34 AM PDT Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment: Clinical Trials Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment Overview: Acute Respiratory Distress Syndrome is an acute lung dysfunction, which occurs as a result of injury or illness. It is known as adult res

“Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance - The BMJ” plus 2 more

Image
“Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance - The BMJ” plus 2 more Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance - The BMJ They were dealt a 'death sentence.' Here's how 2 sisters with cystic fibrosis have persevered - Press & Sun-Bulletin What you need to know about Legionnaires' disease - Gwinnettdailypost.com Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance - The BMJ Posted: 29 Jul 2019 03:22 AM PDT Nicholas S Hopkinson , reader in respiratory medicine and honorary consultant physician 1 , Andrew Molyneux , consultant physician in respiratory and medicine and chair of Guideline Committee 2 , Joshua Pink , technical advisor 3 , Marie C Harrisingh , senior technical analyst 3 on behalf of the Guideline Committee (GC)